Literature DB >> 2547944

Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.

R Patacchini1, C A Maggi, P Rovero, D Regoli, G Drapeau, A Meli.   

Abstract

We have assessed the ability of thiorphan, an inhibitor of enkephalinase, to influence the potentiation of the nerve-mediated contractions of the rat isolated vas deferens (pars prostatica) by mammalian tachykinins [substance P, (SP); neurokinin A (NKA); and neurokinin B (NKB)] and selective tachykinin agonists. In the absence of thiorphan, the rank order of potency of mammalian tachykinins was NKA greater than NKB much greater than SP. The maximal response to SP did not exceed 40% of that to NKA or NKB. Thiorphan (10 microM) had no effect on twitches per se, but increased the potency and maximum effect of mammalian tachykinins. [Pro9]-SP sulfone, a selective NK-1 receptor agonist had no effect, either in the absence or presence of thiorphan. [MePhe7]-NKB had some potentiating effect, but only at micromolar concentrations. [Nle10]-NKA (4-10) and [beta-Ala8]-NKA (4-10), two selective NK-2 agonists displayed good activity. [Nle10]-NKA (4-10) was potentiated by thiorphan. On the other hand, the action of [beta Ala8]-NKA (4-10) was completely thiorphan-resistant. These findings indicate that estimate of activity of tachykinins and tachykinin related peptides in this bioassay is influenced markedly by peptide degradation via a thiorphan-sensitive mechanism. NK-2 receptors are the main if not the sole mediators of the response to tachykinins in this bioassay organ.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547944

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of capsaicin-sensitive afferents in the guinea-pig isolated bronchus.

Authors:  C A Maggi; R Patacchini; F Perretti; S Meini; S Manzini; P Santicioli; E Del Bianco; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

2.  Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.

Authors:  C A Maggi; R Patacchini; S Giuliani; P Rovero; S Dion; D Regoli; A Giachetti; A Meli
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  Tachykinin receptors in the circular muscle of the guinea-pig ileum.

Authors:  C A Maggi; R Patacchini; A Giachetti; A Meli
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

4.  Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.

Authors:  M G Belvisi; R Patacchini; P J Barnes; C A Maggi
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

5.  Characterization of the tachykinin NK2 receptor in the human bronchus: influence of amastatin-sensitive metabolic pathways.

Authors:  M Astolfi; S Treggiari; A Giachetti; S Meini; C A Maggi; S Manzini
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.